Theseus Pharmaceuticals (THRX) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free THRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Theseus Pharmaceuticals Short Interest DataCurrent Short Volume401,700 sharesPrevious Short Volume527,500 sharesChange Vs. Previous Month-23.85%Dollar Volume Sold Short$1.63 millionShort Interest Ratio / Days to Cover0.5Last Record DateJanuary 31, 2024Outstanding Shares44,230,000 sharesFloat Size15,300,000 sharesShort Percent of Float2.63%Today's Trading Volume0 sharesAverage Trading Volume592,167 sharesToday's Volume Vs. Average0% Short Selling Theseus Pharmaceuticals ? Sign up to receive the latest short interest report for Theseus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTHRX Short Interest Over TimeTHRX Days to Cover Over TimeTHRX Percentage of Float Shorted Over Time Ad Paradigm PressBiden out June 13; Kamala won’t replace him?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Theseus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2024401,700 shares $1.63 million -23.9%2.6%0.5 $4.06 1/15/2024527,500 shares $2.13 million -9.9%3.5%0.7 $4.03 12/31/2023585,500 shares $2.37 million -37.5%3.8%0.8 $4.05 12/15/2023936,000 shares $3.51 million -42.2%6.1%1.5 $3.75 11/30/20231,620,000 shares $6.17 million +43.4%10.9%2.8 $3.81 11/15/20231,130,000 shares $3.73 million +9.7%6.9%2.1 $3.30 Get the Latest News and Ratings for THRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theseus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/31/20231,030,000 shares $2.37 million -2.8%8.1%8.3 $2.30 10/15/20231,060,000 shares $2.49 million -0.9%8.3%5.8 $2.35 9/30/20231,070,000 shares $2.88 million +2.9%8.4%1.7 $2.69 9/15/20231,040,000 shares $3.01 million +4.0%8.1%1.6 $2.89 8/31/20231,000,000 shares $3.14 million +6.7%7.3%1.5 $3.14 8/15/2023937,400 shares $2.86 million -12.4%6.8%1.3 $3.06 7/31/20231,070,000 shares $3.61 million -21.9%7.8%1.6 $3.37 7/15/20231,370,000 shares $3.64 million -4.9%10.0%2.2 $2.66 6/30/20231,440,000 shares $13.44 million +25.2%9.5%9 $9.33 6/15/20231,150,000 shares $10.38 million +2.7%7.6%7 $9.03 5/31/20231,120,000 shares $8.15 million -4.3%7.4%7.3 $7.28 5/15/20231,170,000 shares $12.66 million +3.5%7.7%10 $10.82 4/30/20231,130,000 shares $11.57 million -5.0%8.9%9.4 $10.24 4/15/20231,190,000 shares $11.27 million -4.0%9.4%6.3 $9.47 3/31/20231,240,000 shares $11.01 million +10.7%13.2%5 $8.88 3/15/20231,120,000 shares $8.23 million +2.8%11.9%4.1 $7.35 2/28/20231,090,000 shares $10.12 million +13.3%11.6%4.3 $9.28 2/15/2023962,400 shares $10.68 million +7.8%10.2%3.9 $11.10 1/31/2023893,100 shares $12.49 million +12.9%10.3%3.8 $13.99 1/15/2023791,000 shares $7.59 million -3.8%7.2%3.6 $9.60 12/30/2022822,000 shares $4.09 million +1.7%7.5%6.1 $4.98 12/15/2022808,200 shares $4.75 million -2.0%7.1%10.6 $5.88 11/30/2022824,800 shares $5.44 million -5.8%7.2%11.1 $6.59 11/15/2022875,100 shares $5.88 million -6.7%7.6%11.6 $6.72 10/31/2022937,600 shares $5.04 million -0.7%8.1%13 $5.38 10/15/2022944,600 shares $5.53 million -0.6%8.1%20.9 $5.85 9/30/2022950,600 shares $5.51 million +2.9%8.2%20.7 $5.80 9/15/2022923,500 shares $6.32 million +0.8%7.9%14.8 $6.84 8/31/2022916,100 shares $6.25 million -5.3%7.9%11.2 $6.82 8/15/2022967,400 shares $7.84 million -2.1%8.3%10.3 $8.10 7/31/2022988,100 shares $7.12 million -2.2%8.5%9.7 $7.21 7/15/20221,010,000 shares $6.91 million -2.9%8.7%9.9 $6.84 6/30/20221,040,000 shares $5.75 million +5.3%8.9%10.3 $5.53 6/15/2022988,000 shares $5.45 million -0.2%8.5%11.1 $5.52Biden out June 13; Kamala won’t replace him? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. THRX Short Interest - Frequently Asked Questions What is Theseus Pharmaceuticals' current short interest? Short interest is the volume of Theseus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 401,700 shares of THRX short. 2.63% of Theseus Pharmaceuticals' shares are currently sold short. Learn More on Theseus Pharmaceuticals' current short interest. What is a good short interest percentage for Theseus Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.63% of Theseus Pharmaceuticals' floating shares are currently sold short. Is Theseus Pharmaceuticals' short interest increasing or decreasing? Theseus Pharmaceuticals saw a drop in short interest during the month of January. As of January 31st, there was short interest totaling 401,700 shares, a drop of 23.8% from the previous total of 527,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Theseus Pharmaceuticals' float size? Theseus Pharmaceuticals currently has issued a total of 44,230,000 shares. Some of Theseus Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Theseus Pharmaceuticals currently has a public float of 15,300,000 shares. How does Theseus Pharmaceuticals' short interest compare to its competitors? 2.63% of Theseus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Theseus Pharmaceuticals: NGM Biopharmaceuticals, Inc. (4.52%), Kinnate Biopharma Inc. (2.01%), Omeros Co. (23.62%), 908 Devices Inc. (5.16%), Kodiak Sciences Inc. (3.76%), INmune Bio, Inc. (12.66%), Alpha Tau Medical Ltd. (0.08%), Candel Therapeutics, Inc. (12.96%), Skye Bioscience, Inc. (0.29%), The Joint Corp. (5.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Theseus Pharmaceuticals stock? Short selling THRX is an investing strategy that aims to generate trading profit from Theseus Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Theseus Pharmaceuticals? A short squeeze for Theseus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of THRX, which in turn drives the price of the stock up even further. How often is Theseus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including THRX, twice per month. The most recent reporting period available is January, 31 2024. More Short Interest Resources from MarketBeat Related Companies: NGM Short Interest Data KNTE Short Interest Data OMER Short Interest Data MASS Short Interest Data KOD Short Interest Data INMB Short Interest Data DRTS Short Interest Data CADL Short Interest Data SKYE Short Interest Data JYNT Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:THRX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlace